Contacts

Devon Energy Tower 1400 Smith Street, Houston Texas 77007

Contact telephone: +1 888- 614-1227 toll free

  • Product and Service Availability. Regeneceutical PLC- frequently updates and improves its products.
Nothing in the Terms of Use shall be construed as a solicitation for or promotion of, any product or the use of any product that is not authorized by the laws and regulations of the state where you reside or access the Sites. The Power To Heal Tm is a Registered United States Trade Mark of the Morgan Barclay Trust . Patents. All patents issued to and patent applications filed or assigned conditionally to Regeneceutical PLC, Cardio-Matrex Tissue Engineering; Neocardiogenesis Foundation; Paradigm Electroceuticals , are the property of company and are protected by United States and foreign patent laws. Any use of these patented or patentable assets is prohibited without the specific prior written consent of MBMC.  Forward-Looking Statements: Our public communications and SEC filings may contain "forward-looking statements" – that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," or "target." Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about our announced plan filing a Reg A+ securities offering affecting the products and services businesses, (Verticals); expected income; earnings per share; revenues; organic growth; growth of our Digital business; margins; cost structure; restructuring charges; cash flows; return on capital; capital expenditures, capital allocation or capital structure; dividends; and the split between earnings. For us, particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include: obtaining (or the timing of obtaining) any required regulatory reviews or approvals or any other consents or our ability to reduce costs as we execute that plan; changes in law, economic and financial conditions, including interest and exchange rate volatility, commodity and equity prices and the value of financial assets, including the impact of these conditions on our ability to sell or the value of incremental assets to be sold as part of our announced plan. The Health Insurance Portability & Accountability Act of 1996 (HIPAA) requires all health care records and other individually identifiable health information used or disclosed to us in any form, whether electronically, on paper, or orally, be kept confidential. This federal law gives you, the patient, significant new rights to understand and control how your health information is used. Fair Use Notice: This message may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance the understanding of environmental, political, human rights, economic, democracy, scientific, healthcare, social justice issues, etc. We believe this constitutes a ‘fair use’ of any copyrighted material as provided for in Section 17 U.S.C. Section 107.
Regeneceutical PLC
1400 Smith St;
Houston, Texas 77002
Telephone: +1 888- 614-1227
FAX: +1 800 889 9898
E-mail: Webmaster -  regeneceutical@gmail.com

Contact form